enVVeno Medical (NASDAQ:NVNO) Issues Quarterly Earnings Results

enVVeno Medical (NASDAQ:NVNO) posted its earnings results on Thursday. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.33) by ($0.02), Zacks reports.

enVVeno Medical Stock Down 0.6 %

NVNO stock traded down $0.02 during midday trading on Friday, hitting $3.35. The company’s stock had a trading volume of 75,755 shares, compared to its average volume of 103,098. enVVeno Medical has a 1 year low of $3.01 and a 1 year high of $6.97. The stock has a market cap of $44.66 million, a price-to-earnings ratio of -2.60 and a beta of 1.21. The stock’s 50-day moving average price is $4.18 and its 200 day moving average price is $4.81.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).